- Corporate Officers - A
- Alder Matthias
Insider Trading History of Alder Matthias
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Alder Matthias since 2010.
This trader's CIK number is 1370820.
At the time of last reporting, Alder Matthias was the Chief Executive Officer of Gain Therapeutics, Inc.. (stock ticker symbol GANX).
Also see all insider trading activities at Gain Therapeutics, Inc..
Note that in the past
Alder Matthias also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cancervax Corp (MITI) by Alder Matthias
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | MITI | 0 | $0 | 20,000 | $154,110 | 20,000 | $35,000 |
Yearly summary of insider trading at Gain Therapeutics, Inc. (GANX) by Alder Matthias
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | GANX | 0 | $0 | 0 | $0 | 20,212 | $0 |
| 2023 | GANX | 0 | $0 | 2,026 | $5,056 | 8,137 | $0 |
Yearly summary of insider trading at Sucampo Pharmaceuticals, Inc. (SCMP) by Alder Matthias
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | SCMP | 0 | $0 | 150,000 | $2,400,368 | 150,000 | $1,249,499 |
Insider trading activities at 3 companies by Alder Matthias:
1. Cancervax Corp (MITI)
2. Gain Therapeutics, Inc. (GANX)
3. Sucampo Pharmaceuticals, Inc. (SCMP)
Table 1. Insider trading of Cancervax Corp (MITI) by Alder Matthias
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-01-25 | MITI | Option Ex | 10,000 | 1.75 | 17,500 |
| 2010-01-25 | MITI | Sale | 10,000 | 8.25 | 82,540 |
| 2010-01-19 | MITI | Option Ex | 10,000 | 1.75 | 17,500 |
| 2010-01-19 | MITI | Sale | 10,000 | 7.16 | 71,570 |
Table 2. Insider trading of Gain Therapeutics, Inc. (GANX) by Alder Matthias
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-03-26 | GANX | Option Ex | 20,212 | .00 | 0 |
| 2023-12-20 | GANX | Option Ex | 637 | .00 | 0 |
| 2023-12-21 | GANX | Sale | 206 | 2.46 | 506 |
| 2023-12-07 | GANX | Sale | 1,820 | 2.50 | 4,550 |
| 2023-10-01 | GANX | Option Ex | 825 | .00 | 0 |
| 2023-10-01 | GANX | Option Ex | 825 | .00 | 0 |
| 2023-09-20 | GANX | Option Ex | 2,550 | .00 | 0 |
| 2023-07-01 | GANX | Option Ex | 3,300 | .00 | 0 |
Table 3. Insider trading of Sucampo Pharmaceuticals, Inc. (SCMP) by Alder Matthias
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-11-28 | SCMP | Sale | 24,975 | 16.73 | 417,831 |
| 2016-11-23 | SCMP | Option Ex | 26,000 | 8.33 | 216,580 |
| 2016-11-23 | SCMP | Sale | 26,000 | 15.77 | 410,020 |
| 2016-11-25 | SCMP | Option Ex | 99,025 | 8.33 | 824,878 |
| 2016-11-25 | SCMP | Sale | 99,025 | 15.88 | 1,572,517 |
| 2016-11-28 | SCMP | Option Ex | 24,975 | 8.33 | 208,041 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Alder Matthias
(Chief Executive Officer of Gain Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.